What is Neurocept's corporate history and who are its founders?
Executive summary
Neurocept appears in two different corporate guises in available reporting: a UK-registered NEUROCEPT LIMITED (Companies House company number 09882135) with filings and a registered address in Birmingham [1], and a U.S.-marketed dietary supplement brand called Neurocept with multiple commercial sites and news releases announcing a 2025 product launch [2] [3]. Available sources do not provide a single, authoritative founders list tying those entities together or naming founders for the supplement brand; Companies House lists company officers for NEUROCEPT LIMITED but those officer names are not included in the search snippets provided here [4] [1].
1. Two “Neurocepts” in the record — same name, different footprints
Public records show NEUROCEPT LIMITED registered in the U.K., with a Companies House entry (company number 09882135) and a filing history plus a Birmingham registered office address [4] [1]. Separately, numerous commercial webpages and press releases promote a consumer supplement called Neurocept (branded as “Neurocept™” or “Neurocept Cognitive Support”) that recently entered U.S. markets in 2025 according to a GlobeNewswire release and multiple domain sites [3] [2] [5] [6] [7] [8] [9]. The sources do not explicitly connect the U.K. company record to the U.S. supplement marketing network; available sources do not mention a corporate relationship between NEUROCEPT LIMITED (UK) and the U.S. supplement brands.
2. What Companies House shows — a registered U.K. entity exists
Companies House is the authoritative registry for U.K. companies; it lists NEUROCEPT LIMITED with the filing history and people pages referenced in search results [4] [1]. The snippet includes the registered office address at Trafalgar House, Alcester Road South, Birmingham, B14 6DT [1]. The provided search results include links to the company overview and filing history but do not include the names of officers in the snippets I was given; therefore the precise officer/founder names from Companies House are not present in the available excerpts [4] [1]. Available sources do not mention the company’s incorporation date or statement of business activities in the provided snippets.
3. The supplement brand — heavy marketing, multiple domains, and PR
The Neurocept supplement appears promoted across a constellation of domains (neurocept.co, neurocept-us.us, en-us-neurocept.com, us-neurocept.com) and is described as a nootropic/dietary supplement for memory and focus [2] [5] [6] [7] [8] [9]. A GlobeNewswire/press-release-style article frames Neurocept as “officially entered the U.S. wellness market” in November 2025 and emphasizes evidence-based ingredient selection [3]. Newswire-style outlets and review sites publish favorable product-focused coverage and consumer testimonials [10] [3] [11]. Those commercial and PR materials do not identify corporate founders or give verifiable company officer details in the snippets provided.
4. Conflicting signals and consumer complaints
Third‑party reviews and Trustpilot entries warn of potential issues: Trustpilot reviewers allege misleading advertising (including claims about use of public figures via AI) and ingredient discrepancies; reviewers call the product a “scam” in some instances [12]. These consumer complaints raise reputational questions about the supplement brand but do not, in the available snippets, identify founders or corporate officers behind the advertised product [12].
5. What is not found in current reporting — founders and definitive ownership
None of the supplied sources’ snippets provide a clear, attributable list of founders for either the U.K. NEUROCEPT LIMITED filing or the U.S. Neurocept supplement brand [4] [1] [2] [3]. Available sources do not mention names tying the supplement marketing network to the Companies House entry. If you need founder names or the corporate linkage between the registered U.K. company and the marketed supplement, check the full Companies House people page and filing documents and request corporate transparency from the brand’s domain registrant or the press-release issuer; those primary-source documents are referenced but not quoted in the snippets here [4] [1] [3].
6. How to verify — steps and documents to request
To establish corporate history and founders, retrieve the full Companies House filings and “people” page for NEUROCEPT LIMITED (the links are in the Companies House results) to read officer appointments and incorporation filings [4] [1]. For the supplement business, request press‑release contact details and WHOIS/registrar data for the brand domains, and ask the PR distributor (e.g., GlobeNewswire) for the issuer’s corporate identity referenced in their release [3]. The sources above point to these records but do not themselves include the founder names in the excerpts provided [4] [1] [3].
Limitations: I rely only on the supplied search results; the snippets do not contain officer/founder names or an explicit corporate linkage between the U.K. company filing and the U.S. supplement marketing. Where sources are silent, I state that the information is not found in current reporting [4] [1] [2] [3].